OBJECTIVES: Urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase
(ESBL)-producing Enterobacteriaceae are on the increase. Although cefmetazole is stable …

The aim of this study was to evaluate the effectiveness of cefepime compared with
carbapenems for the management of urinary tract infections (UTIs) caused by extended …

Introduction The frequency of urinary tract infections (UTIs) caused by extended-spectrum β-
lactamase (ESBL)-producing Enterobacterales is steadily increasing worldwide. Therefore …

Purpose We determined the prevalence of ESBL Enterobacteriaceae in urinary tract
infections among inpatients, identified risk factors of acquisition, and evaluated the …

Cefmetazole is active against extended-spectrum β-lactamase-producing Escherichia coli
(ESBLEC) and is a potential candidate for carbapenem-sparing therapy. This multicenter …

Background: Much controversy exists as to whether cephalosporin treatment is appropriate
for infections caused by ESBL-producing organisms because no randomized controlled …

ESBL-producing Enterobacteriaceae as uropathogens have given rise to a sizeable amount
of global morbidity. Community and hospital surveillance studies continue to report …

Introduction Frequent use of different antibiotics to treat urinary tract infections (UTIs) exerts
a variety of selective pressure on pathogens which ultimately lead to the antimicrobial …

Background Due to limited therapeutic options, the spread of extended-spectrum beta-
lactamases (ESBLs) have become a major public health concern. We conducted a …

Abstract Background: Urinary tract infections (UTIs) are a problem frequently encountered by
paediatric healthcare providers. Recent data suggest that extended-spectrum β-lactamase …